Brain Tumors in Elderly
International Clinical Neuroscience Journal,
Vol. 2 No. 2 (2015),
1 August 2015
Brain tumors in elderly are increasing as the number of people, who comprise the older population, does.About half of the patients with brain tumors appear to be over 60 years of age.In this review article, Glioblastoma multiform, as the most common malignant tumor of the central nervous system in elderly is discussed in details of definition, prognosis, diagnosis, treatment and differential diagnosis. Other tumors such as meningioma, pituitary adenoma, CNS lymphoma and metastasis are also included to be reviewed. Treatment plans, either conservative or aggressive, classic or novel, approved or under investigation, are presented. Furthermore different attitudes of treatment in the past and recently are also argued. Conventional therapy, Surgery, Radiotherapy, chemotherapy radioimmunotherapy, hormonal therapy and some other novel methods of treatments are discussed in details for the glioma.
Determining factors which may be associated to the patient's response to each treatment planare also discussed. Finally, some age related issues are provided to be paid attention to consider an old patient with brain tumor, and planning an optimal treatment in order to make the best management decisions.Until recently, peoplewith brain tumors in elderly, were used to be treated in conservative plans and often were excluded of the clinical trials but now the number of patients who desire and receive more aggressive therapy for brain tumors is increasing.
- Brain Tumor
How to Cite
Flowers A. Brain tumors in the older person. Cancer control. 2000;7(6):523-38.
Larsen NS. Brain tumor incidence rising; researchers ask why. Journal of the National Cancer Institute. 1993;85(13):1024-5.
Laws ER, Thapar K. Brain tumors. CA: a cancer journal for clinicians. 1993;43(5):263-71.
SCHOENBERG BS, CHRISTINE BW, WHISNANT JP. Nervous system neoplasms and primary malignancies of other sites The unique association between meningiomas and breast cancer. Neurology. 1975;25(8):705-.
Ahsan H, Neugut AI, Bruce JN. Association of malignant brain tumors and cancers of other sites. Journal of clinical oncology. 1995;13(12):2931-5.
Mack W, Preston‐Martin S, Peters JM. Astrocytoma risk related to job exposure to electric and magnetic fields. Bioelectromagnetics. 1991;12(1):57-66.
Tsang R, Laperriere N, Simpson W, Brierley J, Panzarella T, Smyth H. Glioma arising after radiation therapy for pituitary adenoma. A report of four patients and estimation of risk. Cancer. 1993;72(7):2227-33.
Preston-Martin S, Staples M, Farrugia H, Giles G. Primary tumors of the brain, cranial nerves and cranial meninges in Victoria, Australia, 1982–1990: patterns of incidence and survival. Neuroepidemiology. 1993;12(5):270-9.
Radhakrishnan K, Mokri B, Parisi JE, O'Fallon WM, Sunku J, Kurland LT. The trends in incidence of primary brain tumors in the population of Rochester, Minnesota. Annals of neurology. 1995;37(1):67-73.
Grieg NH, Ries LG, Yancik R, Rapoport SI. Increasing annual incidence of primary malignant brain tumors in the elderly. Journal of the National Cancer Institute. 1990;82(20):1621-4.
Ahsan H, Neugut AI, Bruce JN. Trends in incidence of primary malignant brain tumors in USA, 1981–1990. International journal of epidemiology. 1995;24(6):1078-85.
Takeuchi K, Sano K, Nomura K. An epidemiological study of brain tumours in the elderly. Neurological research. 1991;13(1):21.
Desmeules M, Mikkelsen T, Mao Y. Increasing incidence of primary malignant brain tumors: influence of diagnostic methods. Journal of the National Cancer Institute. 1992;84(6):442-5.
Chaichana KL, Garzon-Muvdi T, Parker S, Weingart JD, Olivi A, Bennett R, et al. Supratentorial glioblastoma multiforme: the role of surgical resection versus biopsy among older patients. Annals of surgical oncology. 2011;18(1):239-45.
Tomita T, Raimondi AJ. Brain tumors in the elderly. Jama. 1981;246(1):53-5.
Layon AJ, George BE, Hamby B, Gallagher TJ. Do elderly patients overutilize healthcare resources and benefit less from them than younger patients? A study of patients who underwent craniotomy for treatment of neoplasm. Critical care medicine. 1995;23(5):829-34.
Halperin EC. Malignant gliomas in older adults with poor prognostic signs. Getting nowhere, and taking a long time to do it. Oncology (Williston Park, NY). 1995;9(3):229-34; discussion 37-8, 43.
Kallio M. Therapy and survival of adult patients with intracranial glioma in a defined population. Acta neurologica Scandinavica. 1990;81(6):541-9.
Vecht CJ. Effect of age on treatment decisions in low-grade glioma. Journal of Neurology, Neurosurgery & Psychiatry. 1993;56(12):1259-64.
Lote K, Egeland T, Hager B, Stenwig B, Skullerud K, Berg-Johnsen J, et al. Survival, prognostic factors, and therapeutic efficacy in low-grade glioma: a retrospective study in 379 patients. Journal of clinical oncology. 1997;15(9):3129-40.
Fernandez PM, Brem S. Malignant brain tumors in the elderly. Clinics in geriatric medicine. 1997;13(2):327-38.
Philippon JH, Clemenceau SH, Fauchon FH, Foncin JF. Supratentorial Low‐Grade Astrocytomas in Adults. Neurosurgery. 1993;32(4):554-9.
Flowers A. Brain tumors. Comprehensive Geriatric Oncology Amsterdam, The Netherlands: Harwood Academic. 1998:703-19.
Wegmann J. CNS tumors: supportive management of the patient and family. Oncology (Williston Park, NY). 1991;5(11):109-13; discussion 13-4, 16.
Albritton K, Bleyer W. The management of cancer in the older adolescent. European Journal of Cancer. 2003;39(18):2584-99.
Black PM. Brain tumors. New England Journal of Medicine. 1991;324(22):1555-64.
Mineura K, Sasajima T, Kowada M, Ogawa T, Hatazawa J, Shishido F, et al. Perfusion and metabolism in predicting the survival of patients with cerebral gliomas. CANCER-PHILADELPHIA-. 1994;73:2386-.
Nelson DF, Nelson JS, Davis DR, Chang CH, Griffins TW, Pajak TF. Survival and prognosis of patients with astrocytoma with atypical or anaplastic features. Journal of neuro-oncology. 1985;3(2):99-103.
Shaw EG, Scheithauer BW, O'Fallon JR, Davis DH. Mixed oligoastrocytomas: a survival and prognostic factor analysis. Neurosurgery. 1994;34(4):577-82.
Party MBTW. Prognostic factors for high-grade malignant glioma: development of a prognostic index. J Neurooncol. 1990;9(1):47-55.
Salmon I, Dewitte O, Pasteels J-L, Flament-Durand J, Brotchi J, Vereerstraeten P, et al. Prognostic scoring in adult astrocytic tumors using patient age, histopathological grade, and DNA histogram type. Journal of neurosurgery. 1994;80(5):877-83.
Burger PC, Green SB. Patient age, histologic features, and length of survival in patients with glioblastoma multiforme. Cancer. 1987;59(9):1617-25.
Steck P, Bruner J, Pershouse M, Hadi A. Molecular, genetic, and biologic aspects of primary brain tumors. CANCER BULLETIN-HOUSTON-. 1993;45:296-.
McKeever PE, Strawderman MS, Yamini B, Mikhail AA, Blaivas M. MIB-1 proliferation index predicts survival among patients with grade II astrocytoma. Journal of Neuropathology & Experimental Neurology. 1998;57(10):931-6.
Brandes AA, Franceschi E, Tosoni A, Blatt V, Pession A, Tallini G, et al. MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients. Journal of Clinical Oncology. 2008;26(13):2192-7.
van den Bent MJ, Dubbink HJ, Sanson M, van der Lee-Haarloo CR, Hegi M, Jeuken JW, et al. MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951. Journal of Clinical Oncology. 2009;27(35):5881-6.
Wood JR, Green SB, Shapiro WR. The prognostic importance of tumor size in malignant gliomas: a computed tomographic scan study by the Brain Tumor Cooperative Group. Journal of clinical oncology. 1988;6(2):338-43.
Devaux BC, O'Fallon JR, Kelly PJ. Resection, biopsy, and survival in malignant glial neoplasms: a retrospective study of clinical parameters, therapy, and outcome. Journal of neurosurgery. 1993;78(5):767-75.
Ammirati M, Vick N, Liao Y, Ciric I, Mikhael M. Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas. Neurosurgery. 1987;21(2):201-6.
Keles GE, Anderson B, Berger MS. The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere. Surgical neurology. 1999;52(4):371-9.
Andreou J, George AE, Wise A, de Leon M, Kricheff II, Ransohoff J, et al. CT prognostic criteria of survival after malignant glioma surgery. American Journal of Neuroradiology. 1983;4(3):488-90.
Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. The Lancet Oncology. 2009;10(5):459-66.
Chamberlain MC. Treatment options for glioblastoma. Neurosurgical focus. 2006;20(4):E19.
Khasraw M, Lassman AB. Advances in the treatment of malignant gliomas. Current oncology reports. 2010;12(1):26-33.
Hess KR. Extent of resection as a prognostic variable in the treatment of gliomas. Journal of neuro-oncology. 1999;42(3):227-31.
Albert FK, Forsting M, Sartor K, Adams H-P, Kunze S. Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery. 1994;34(1):45-61.
Salcman M, Kaplan RS, Ducker TB, Abdo H, Montgomery E. Effect of age and reoperation on survival in the combined modality treatment of malignant astrocytoma. Neurosurgery. 1982;10(4):454-63.
Fadul C, Wood J, Thaler H, Galicich J, Patterson R, Posner J. Morbidity and mortality of craniotomy for excision of supratentorial gliomas. Neurology. 1988;38(9):1374-.
Awad IA, Kalfas I, Hahn JF, Little JR. Intracranial meningiomas in the aged: surgical outcome in the era of computed tomography. Neurosurgery. 1989;24(4):557-60.
Fujimura M, Kumabe T, Tominaga T, Jokura H, Shirane R, Yoshimoto T. Routine clinical adoption of magnetic resonance imaging was associated with better outcome after surgery in elderly patients with a malignant astrocytic tumour: a retrospective review. Acta neurochirurgica. 2004;146(3):251-5.
Gijtenbeek J, Hop W, Braakman R, Avezaat C. Surgery for intracranial meningiomas in elderly patients. Clinical neurology and neurosurgery. 1993;95(4):291-5.
Kelly PJ, Hunt C. The limited value of cytoreductive surgery in elderly patients with malignant gliomas. Neurosurgery. 1994;34(1):62-7.
Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. Journal of neurosurgery. 2001;95(2):190-8.
Vives KP, Piepmeier JM. Complications and expected outcome of glioma surgery. Journal of Neuro-oncology. 1999;42(3):289-302.
Sheline GE. Radiation therapy of brain tumors. Cancer. 1977;39(S2):873-81.
Shaw EG. Low-Grade Gliomas: To Treat or Not to Treat?: A Radiation Oncologist's Viewpoint. Archives of neurology. 1990;47(10):1138-9.
Peschel RE, Wilson L, Haffty B, Papadopoulos D, Rosenzweig K, Feltes M. The effect of advanced age on the efficacy of radiation therapy for early breast cancer, local prostate cancer and grade III–IV gliomas. International Journal of Radiation Oncology* Biology* Physics. 1993;26(3):539-44.
Shibamoto Y, Yamashita J, Takahashi M, Yamasaki T, Kikuchi H, Abe M. Supratentorial malignant glioma: an analysis of radiation therapy in 178 cases. Radiotherapy and Oncology. 1990;18(1):9-17.
Villà S, Viñolas N, Verger E, Yaya R, Martı́nez A, Gil M, et al. Efficacy of radiotherapy for malignant gliomas in elderly patients. International Journal of Radiation Oncology* Biology* Physics. 1998;42(5):977-80.
Cao JQ, Fisher BJ, Bauman GS, Megyesi JF, Watling CJ, Macdonald DR. Hypofractionated radiotherapy with or without concurrent temozolomide in elderly patients with glioblastoma multiforme: a review of ten-year single institutional experience. Journal of neuro-oncology. 2012;107(2):395-405.
Hoegler DB, Davey P. A prospective study of short course radiotherapy in elderly patients with malignant glioma. Journal of neuro-oncology. 1997;33(3):201-4.
Hercbergs AA, Tadmor R, Findler G, Sahar A, Brenner H. Hypofractionated radiation therapy and concurrent cisplatin in malignant cerebral gliomas. Rapid palliation in low performance status patients. Cancer. 1989;64(4):816-20.
Kleinberg L, Grossman S, Carson K, Lesser G, O’Neill A, Pearlman J, et al. Survival of patients with newly diagnosed glioblastoma multiforme treated with RSR13 and radiotherapy: results of a phase II new approaches to brain tumor therapy CNS consortium safety and efficacy study. Journal of clinical oncology. 2002;20(14):3149-55.
Sheline GE, Wara WM, Smith V. Therapeutic irradiation and brain injury. International Journal of Radiation Oncology* Biology* Physics. 1980;6(9):1215-28.
Tsuruda JS, Kortman KE, Bradley WG, Wheeler DC, Van Dalsem W, Bradley TP. Radiation effects on cerebral white matter: MR evaluation. American journal of neuroradiology. 1987;8(3):431-7.
Armstrong C, Ruffer J, Corn B, DeVries K, Mollman J. Biphasic patterns of memory deficits following moderate-dose partial-brain irradiation: neuropsychologic outcome and proposed mechanisms. Journal of clinical oncology. 1995;13(9):2263-71.
Belanich M, Pastor M, Randall T, Guerra D, Kibitel J, Alas L, et al. Retrospective study of the correlation between the DNA repair protein alkyltransferase and survival of brain tumor patients treated with carmustine. Cancer Research. 1996;56(4):783-8.
Friedman HS, McLendon RE, Kerby T, Dugan M, Bigner SH, Henry AJ, et al. DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma. Journal of Clinical Oncology. 1998;16(12):3851-7.
Donelli M, Zucchetti M, D'Incalci M. Do anticancer agents reach the tumor target in the human brain? Cancer chemotherapy and pharmacology. 1992;30(4):251-60.
Yung WA, Prados MD, Yaya-Tur R, Rosenfeld SS, Brada M, Friedman HS, et al. Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Journal of Clinical Oncology. 1999;17(9):2762-.
Krishnasamy S, Vokes EE, Dohrmann GJ, Mick R, Garcia JC, Kolker JD, et al. Concomitant chemoradiotherapy, neutron boost, and adjuvant chemotherapy for anaplastic astrocytoma and glioblastoma multiforme. Cancer investigation. 1995;13(5):453-9.
Riva P, Arista A, Tison V, Sturiale C, Franceschi G, Spinelli A, et al. Intralesional radioimmunotherapy of malignant gliomas. An effective treatment in recurrent tumors. Cancer. 1994;73(S3):1076-82.
Saris SC, Solares GR, Wazer DE, Cano G, Kerley SE, Joyce MA, et al. Boron neutron capture therapy for murine malignant gliomas. Cancer research. 1992;52(17):4672-7.
Couldwell WT, Weiss MH, DeGiorgio CM, Weiner LP, Hinton DR, Ehresmann GR, et al. Clinical and Radiographic Response in a Minority of Patients with Recurrent Malignant Gliomas Treated with High‐Dose Tamoxifen. Neurosurgery. 1993;32(3):485-90.
Vertosick Jr FT, Selker RG, Pollack IF, Arena V. The treatment of intracranial malignant gliomas using orally administered tamoxifen therapy: preliminary results in a series of “failed” patients. Neurosurgery. 1992;30(6):897-903.
Markert JM, Coen DM, Malick A, Mineta T, Martuza RL. Expanded spectrum of viral therapy in the treatment of nervous system tumors. Journal of neurosurgery. 1992;77(4):590-4.
Ingber D, Fujita T, Kishimoto S, Sudo K, Kanamaru T, Brem H, et al. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature. 1990;348(6301):555-7.
Boviatsis EJ, Bouras TI, Kouyialis AT, Themistocleous MS, Sakas DE. Impact of age on complications and outcome in meningioma surgery. Surgical neurology. 2007;68(4):407-11.
Sheehan J, Douds G, Hill K, Farace E. Transsphenoidal surgery for pituitary adenoma in elderly patients. Acta neurochirurgica. 2008;150(6):571-4.
Kovacs K, Ryan N, Horvath E, Singer W, Ezrin C. Pituitary adenomas in old age. Journal of Gerontology. 1980;35(1):16-22.
Freilich RJ, Delattre J-Y, Monjour A, DeAngelis LM. Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients. Neurology. 1996;46(2):435-9.
Abrey LE, Deangelis LM, Yahalom J. Long-term survival in primary CNS lymphoma. Journal of Clinical Oncology. 1998;16(3):859-63.
Schouten LJ, Rutten J, Huveneers HA, Twijnstra A. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer. 2002;94(10):2698-705.
Jelinek J, Smirniotopoulos JG, Parisi JE, Kanzer M. Lateral ventricular neoplasms of the brain: differential diagnosis based on clinical, CT, and MR findings. American Journal of Neuroradiology. 1990;11(3):567-74.
- Abstract Viewed: 1310 times
- PDF Downloaded: 602 times